Reaction

Implant Site Extravasation reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 781 reports · 5 co-occurring drugs

As of the last recalculation, Implant Site Extravasation appears in 781 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is BUPIVACAINE (PRR 198.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Bupivacaine64198.8200.1
Baclofen22496.897.1
Clonidine4927.127.2
Hydromorphone Hydrochloride6119.119.1
Etonogestrel2313.213.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.